| Product Name | MF | CAS | Details |
|---|
| IKBE antibody (Ser22) | Details |
| Proinsullin, human | Details |
| H-DVSYLYR^-OH | Details |
| Protodeltonin | C51H84O23 | 94992-08-2 | Details |
| D-glucosyl-β-1,1'-N-nervonoyl-D-erythro-sphingosine | C48H91NO8 | 887907-50-8 | Details |
| 3-(Prop-2-yn-1-yloxy)azetidine hydrochloride | C6H10ClNO | 1380571-75-4 | Details |
| 1-(3-Fluorophenyl)-1H-1,2,3-triazole-5-carboxylic acid | C9H6FN3O2 | 1153490-92-6 | Details |
| 1-((4-(tert-butyl)phenyl)sulfonyl)-4-(3-(trifluoromethyl)phenyl)piperazine | C21H25F3N2O2S | 315692-42-3 | Details |
| CM-675 | C31H32N6O3 | 1872466-47-1 | Details |
| 1-(1H-Pyrazol-4-yl)ethan-1-one hydrochloride | C5H7ClN2O | 1803567-08-9 | Details |
| 4-(1-Methyl-1H-pyrazol-4-yl)cyclohexan-1-one | C10H14N2O | 1231258-34-6 | Details |
| Bis[3-(triethoxysilyl)propyl]tetrasulfide | C18H42O6S4Si2 | 40372-72-3 | Details |
| RIP1 Inhibitor II, 7-Cl-O-Nec-1 | C13H12ClN3O2 | 852391-15-2 | Details |
| Methyl linolelaidate | C19H34O2 | 2566-97-4 | Details |
| tert-Butyl 4-aminooxane-4-carboxylate | C10H19NO3 | 1557187-54-8 | Details |
| 4-Chloro-6,7-dimethoxy-quinoline-3-carbonitrile | C12H9ClN2O2 | 214470-55-0 | Details |
| ISYNA1 antibody | Details |
| 9-Bromononanoic acid | C9H17BrO2 | 41059-02-3 | Details |
| Everolimus related compound 3 | C32H49NO9 | 147438-30-0 | Details |
| 2-Methyl-2-[4-(trifluoromethyl)phenyl]propan-1-amine | C11H14F3N | 1004282-76-1 | Details |
| 4-Hydroxy phenylbutazone | C19H20N2O3 | 16860-43-8 | Details |
| N-(4-chlorophenyl)(phenylamino)formamide | C13H11ClN2O | 1967-26-6 | Details |
| 7-Bromo-5-methyl-1H,2H,3H,4H,9H-cyclopenta[b]quinolin-9-one | C13H12BrNO | 1247186-14-6 | Details |
| 5-Fluorobicyclo[4.2.0]octa-1(6),2,4-trien-7-one | C8H5FO | 118112-20-2 | Details |
| 1-(3-Bromophenyl)-2-methoxyethan-1-amine | C9H12BrNO | 1270367-91-3 | Details |
| 2-Methoxy-2-(1-methyl-1H-pyrazol-4-yl)acetic acid | C7H10N2O3 | 1549522-64-6 | Details |
| 1-[4-(Cyclopentyloxy)-3-methoxyphenyl]ethan-1-amine | C14H21NO2 | 954265-01-1 | Details |
| Nordihydroguaiaretic acid - mixture of diastereomers | C18H22O4 | 500-38-9 | Details |
| Byakangelicin | C17H18O7 | 482-25-7 | Details |
| Lup-20(29)-ene-2α,3beta-diol | C30H50O2 | 61448-03-1 | Details |
| 8-Bromo-5-fluoroquinoline-2-carbaldehyde | C10H5BrFNO | 1067914-59-3 | Details |
| 6-Bromo-2,2-dimethyl-3,4-dihydro-2H-1,3-benzoxazin-4-one | C10H10BrNO2 | 133001-95-3 | Details |
| 6-Methylpyridazin-4-amine hydrochloride | C5H8ClN3 | 1892936-61-6 | Details |
| SLC17A1 antibody | Details |
| (R)-N-(8-(2-Hydroxy-3-morpholinopropoxy)-7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)-2-methylnicotinamide | C25H30N6O5 | 1375469-38-7 | Details |
| Brentuximab vedotin | 914088-09-8 | Details |
| 17-Hydroxy-18-dehydroneogrifolin | C22H32O3 | 1630936-42-3 | Details |
| BAY-958 hydrochloride | C17H17ClFN5O3S | 1424871-27-1 | Details |
| 2-(4-Ethylmorpholin-3-yl)acetic acid hydrochloride | 2225146-65-4 | Details |
| 1,3,4,6-Tetra-O-acetyl-2-deoxy-2-fluoro-D-mannopyranose | Details |
| TNFRSF10A Blocking Peptide | Details |
| H-KENALLRYLLDKD-OH | Details |
| Gliovirin | C20H20N2O8S2 | 83912-90-7 | Details |
| 4-Fluoro-3-methoxybenzyl alcohol | C8H9FO2 | 128495-45-4 | Details |
| Cy5.5 Di Et | C37H39IN2 | 123791-69-5 | Details |
| 3-(9H-Purin-6-ylsulfanyl)propanoic acid | C8H8N4O2S | 608-10-6 | Details |
| TC-G 1000 | C17H18N2O4S | 245744-18-7 | Details |
| Ceruloplasmin antibody | Details |
| TFPI antibody | Details |
| Haematoporphyrin | C34H38N4O6 | 14459-29-1 | Details |
| Fbxo34 Blocking Peptide | Details |
| Calcitonin (human) trifluoroacetate salt | C151H226N40O45S3 | 21215-62-3 | Details |
| Mdivi-1 | C15H10Cl2N2O2S | 338967-87-6 | Details |
| CBR-5884 | C14H12N2O4S2 | 681159-27-3 | Details |
| 3-[(Methylcarbamoyl)amino]propanoic acid | C5H10N2O3 | 130912-73-1 | Details |
| 3-Methyl-1H,2H,3H,4H-pyrido[2,3-b]pyrazin-2-one | C8H9N3O | 74983-04-3 | Details |
| 4-Bromo-3,5-dimethylbenzene-1-sulfonyl chloride | C8H8BrClO2S | 1581266-79-6 | Details |
| 1-(Butan-2-yl)-5-methyl-1H-pyrazole-3-carboxylic acid | C9H14N2O2 | 1432680-57-3 | Details |
| Methyl 2,4-Di-O-acetyl-3-deoxy-3-fluoro-b-D-xylopyranoside | C10H15FO6 | 616234-50-5 | Details |
| MUC12 antibody | Details |
| 4-(3,4-Difluorophenyl)butan-2-one | C10H10F2O | 1251925-01-5 | Details |
| 2-{[(tert-Butoxy)carbonyl]amino}-2-(2,5-difluorophenyl)acetic acid | C13H15F2NO4 | 918144-59-9 | Details |
| H-QLLAPGNSAGAFLIR-OH | Details |
| 4-((1-oxo-2-phenylinden-3-yl)amino)benzoic acid | C22H15NO3 | 15255-67-1 | Details |
| 3,4-Dihydro-2H-1-benzothiopyran-4-carbonitrile | C10H9NS | 120783-43-9 | Details |
| N-Cyclopropyl-N-ethylaminosulfonamide | C5H12N2O2S | 1094711-35-9 | Details |
| 2-(Cyclopentylmethyl)-3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoic acid | C24H27NO4 | 1823505-47-0 | Details |
| Streptococcus Group B antibody (FITC) | Details |
| Methyl 2-ethyl-2H-1,2,3-triazole-4-carboxylate | C6H9N3O2 | 215868-68-1 | Details |
| 4-(1-Methyl-1H-pyrazol-4-yl)-2-(piperidin-4-yl)pyrimidine dihydrochloride | C13H18ClN5 | 2060008-63-9 | Details |
| 5-(2-Methylphenyl)imidazolidine-2,4-dione | C10H10N2O2 | 187978-78-5 | Details |
| 2-Amino-N-methylthiophene-3-carboxamide | C6H8N2OS | 252963-49-8 | Details |
| 2-(5-Amino-4-bromo-1H-pyrazol-1-yl)acetic acid hydrobromide | C5H7Br2N3O2 | 1788624-79-2 | Details |
| 1-(2-Methylphenyl)-1H-pyrazole-4-carboxylic acid | C11H10N2O2 | 75815-76-8 | Details |
| 3-((4,5-dichloroimidazolyl)methyl)-4-bromo-2-methyl-1-phenyl-3-pyrazolin-5-one | C14H11BrCl2N4O | 946386-74-9 | Details |
| Enlimomab | 142864-19-5 | Details |
| 2,2,2-Trifluoroethyl 4-(4-hydroxyphenyl)piperazine-1-carboxylate | C13H15F3N2O3 | 1484775-54-3 | Details |
| Biotin-16-deoxycytidine-5'-triphosphate, lithium salt - 1 mM aqueous solution | Details |
| (4-(tert-butyl)phenyl)-N-((pyrimidin-2-ylamino)thioxomethyl)formamide | C16H18N4OS | 1022582-57-5 | Details |
| 6-methylpyridazine-3-carbaldehyde | C6H6N2O | 635324-41-3 | Details |
| Potassium trifluoro(neopentyl)borate | C5H11BF3K | 1150655-02-9 | Details |
| 4-Morpholinopyridin-3-amine | C9H13N3O | 90648-26-3 | Details |
| VPS24 protein (His tag) | Details |
| D-myo-Inositol-1,3,4,5-tetraphosphate sodium salt | C6H8Na8O18P4 | 210488-61-2 | Details |
| 3-{[2-(Aminomethyl)phenyl]methyl}-1,3-diazaspiro[4.5]decane-2,4-dione | C16H21N3O2 | 1016763-30-6 | Details |
| CBFB protein (His tag) | Details |
| H-SLYSYFQK^V-OH | Details |
| (R)-3-tert-Butoxycarbonylamino-heptanoic acid | C12H23NO4 | 854102-50-4 | Details |
| Anti-Sgo1 antibody - 1mg/mL | Details |
| N-[1-(1H-1,3-Benzodiazol-2-yl)ethyl]-4-methylbenzamide | C17H17N3O | 488099-82-7 | Details |
| Cytochrome P450 8B1 antibody | Details |
| 2-Amino-2-(oxan-3-yl)ethan-1-ol hydrochloride | C7H16ClNO2 | 1909308-51-5 | Details |
| RALA Blocking Peptide | Details |
| 3-(Hydroxymethyl)-1-methyl-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one | C7H8N4O2 | 1260656-84-5 | Details |
| Biot-EGPWLEEEEAYGWMDF-NH2 | Details |
| anti-Dog CRP Antibody | Details |
| 3-(1-Benzothiophen-3-yl)-2-oxopropanoic acid | C11H8O3S | 66386-16-1 | Details |
| Lipoamide-dpeg(24)-OMe | C33H65NO13S2 | 1334172-68-7 | Details |
| rac-Methyl (2R,3R)-2-amino-4,4-difluoro-3-hydroxy-3-methylbutanoate hydrochloride | C6H12ClF2NO3 | 1903787-82-5 | Details |
| 3-({[(Benzyloxy)carbonyl]amino}methyl)oxetane-3-carboxylic acid | C13H15NO5 | 2138200-00-5 | Details |
| Product Total： Product Page： | ||||
| 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 | ||||